Curis Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Curis Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Lexington
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: CRIS
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001108205
EIN: 04-3505116

Board of directors

Follow this board

Anne Elizabeth Borgman · Director
Since 2023
James E. Dentzer · Director · President & CEO
Since 2023
John Hohneker · Director
Since 2023
Kenneth I. Kaitin · Director
Since 2023
Marc Rubin · Director
Since 2023
Martyn D. Greenacre · Director
Since 2023

Chief executives

James E. Dentzer · President & CEO

Dates unknown

Director election results

Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Martyn D. Greenacre

98.5%
Kenneth I. Kaitin

99.0%

Board connections

4 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Shared director Other board Same sector

ArriVent BioPharma Inc. Same sector
via John Hohneker
Galectin Therapeutics Inc. Same sector
via Marc Rubin
Imunon Inc. Same sector
via James E. Dentzer
NextCure Inc. Same sector
via Anne Elizabeth Borgman

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $5,500; 1 purchase by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Mar 31, 2026	Kenneth I. Kaitin Director	Open-market purchase	+10,000	$0.55	$5,500
Mar 20, 2026	Zung Jonathan B. Officer (CDO)	Derivative conversion	+66,667	—	—
Mar 20, 2026	Hamdy Ahmed MD Officer (CMO)	Derivative conversion	+66,667	—	—
Mar 20, 2026	Duvall Diantha Officer (CFO)	Derivative conversion	+66,666	—	—
Mar 20, 2026	James E. Dentzer Director, Officer (President & CEO)	Derivative conversion	+133,333	—	—
Mar 20, 2026	Marc Rubin Director	Derivative conversion	+26,667	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Curis Inc.

Who is the CEO of Curis Inc.?

James E. Dentzer is Curis Inc.'s President & CEO.

How many directors are on Curis Inc.'s board?

Curis Inc.'s board has 6 directors: Anne Elizabeth Borgman, James E. Dentzer, John Hohneker, Kenneth I. Kaitin, Marc Rubin and Martyn D. Greenacre.

Are Curis Inc. insiders buying or selling shares?

Over the last 12 months, Curis Inc. insiders bought $5,500 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Curis Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="curis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.